Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Katie Lunnon, PhD, PGCAP, of the University of Exeter, Exeter, UK, discusses the last 5 years in epigenomics for Alzheimer’s. She highlights studies of ANK1 DNA methylation across different neurodegenerative diseases, and explains her further plans for study in this area. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.